Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
McMaster University
$70,000.00
Immune recognition of the Streptococcus milleri Group at sites of natural colonization and infection
FY 2012-13
Summary
The Streptococcus milleri Group (SMG) is a group of bacteria that colonize the upper respiratory, gastrointestinal, and urogenital tract in 15-30% of the healthy population. If the SMG breach these barriers, they are able to access underlying tissue where they cause serious infections, including purulent infections, abscesses in the head, neck, brain and liver, and pulmonary exacerbations in patients with Cystic Fibrosis. Why the SMG go unrecognized by the immune system at certain sites, but are recognized and cause infection at other sites is not known. Our laboratory contains a collection of over 300 clinical isolates of SMG cultured from both healthy individuals and invasive infections. This collection will be surveyed for interactions with the host immune response. We expect that SMG will induce a harmful pro-inflammatory response by cells present at sites of infection, and prevent the pro-inflammatory response from cells present at sites colonization. Strains of SMG will vary in the magnitude of the pro-inflammatory response, falling along a spectrum of less harmful to more-harmful. We will investigate this variation in order to identify microbial and human immune factors that distinguish strains more prone to causing infection. A mouse model of SMG infection will confirm the importance of these factors in causing disease. This research may help understand the mechanisms that the human immune response uses to distinguish colonizing bacteria from infecting bacteria and may identify potential pathways to target with therapeutics.
Department
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
283801
Name
Kaiser Julienne
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Immune recognition of the Streptococcus milleri Group at sites of natural colonization and infection
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$70,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Airway Infections; Innate Immunity; Microbiology
Abstract
The Streptococcus milleri Group (SMG) is a group of bacteria that colonize the upper respiratory, gastrointestinal, and urogenital tract in 15-30% of the healthy population. If the SMG breach these barriers, they are able to access underlying tissue where they cause serious infections, including purulent infections, abscesses in the head, neck, brain and liver, and pulmonary exacerbations in patients with Cystic Fibrosis. Why the SMG go unrecognized by the immune system at certain sites, but are recognized and cause infection at other sites is not known. Our laboratory contains a collection of over 300 clinical isolates of SMG cultured from both healthy individuals and invasive infections. This collection will be surveyed for interactions with the host immune response. We expect that SMG will induce a harmful pro-inflammatory response by cells present at sites of infection, and prevent the pro-inflammatory response from cells present at sites colonization. Strains of SMG will vary in the magnitude of the pro-inflammatory response, falling along a spectrum of less harmful to more-harmful. We will investigate this variation in order to identify microbial and human immune factors that distinguish strains more prone to causing infection. A mouse model of SMG infection will confirm the importance of these factors in causing disease. This research may help understand the mechanisms that the human immune response uses to distinguish colonizing bacteria from infecting bacteria and may identify potential pathways to target with therapeutics.
Competitiondate
201210
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Kaiser, Julienne
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $70,000~ $0~